Advertisement

Detecting Ubiquitinated T-Cell Antigen Receptor Subunits by Immunoblotting

  • Allan M. Weissman
Part of the Methods in Molecular Biology™ book series (MIMB, volume 134)

Abstract

An increasing number of transmembrane proteins are being identified as substrates for ubiquitination. Ubiquitin is a highly conserved 76 amino acid polypeptide that is covalently added to proteins as monomers or chains as a consequence of the formation of an isopeptide linkage between the carboxyl terminus of ubiquitin and the ε-amino groups of lysine side chains of target proteins (reviewed in ref. 1). Classically, modification by ubiquitin results in a change in migration on SDS-PAGE such that modified proteins take on a ladder-like appearance with a periodicity of ∼8 kDa. Alternatively, ubiquitinated species can appear as a high molecular weight smear. Our current understanding is that, for transmembrane proteins, this modification may occur while in the endoplasmic reticulum (ER) or at the plasma membrane. In both cases ubiquitination occurs on the cytosolic (intracellular) domain. Thus, this modification should not affect recognition by antibodies directed against luminal (or extracellular) domains.

Keywords

Proteasome Inhibitor Wash Buffer Phosphatase Inhibitor Amino Acid Polypeptide Lysine Side Chain 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Weissman, A. M. (1997) Regulating protein degradation by ubiquitination. Immunol. Today 18, 189–198.PubMedCrossRefGoogle Scholar
  2. 2.
    Bonifacino, J. S. and Weissman, A. M. (1998) Ubiquitin and the control of protein fate in the secretory and endocytic pathways. Annu. Rev. Cell Dev. Biol. 13, 19–57.CrossRefGoogle Scholar
  3. 3.
    Cenciarelli, C., Hou, D., Hsu, K.-C., Rellahan, B. L., Wiest, D. L., Smith, H. T., Fried, V. A., and Weissman, A. M. (1992) Activation-induced ubiquitination of the T cell antigen receptor. Science 257, 795–797.PubMedCrossRefGoogle Scholar
  4. 4.
    Cenciarelli, C., Wilhelm, K. J., Jr., Guo, A., and Weissman, A. M. (1996) T cell antigen receptor ubiquitination is a consequence of receptor-mediated tyrosine kinase activation. J. Biol. Chem. 271, 8709–8713.PubMedCrossRefGoogle Scholar
  5. 5.
    Yang, M., Omura, S., Bonifacino, J. S., and Weissman, A. M. (1998) Novel aspects of degradation of TCR subunits from the ER in T cells: importance of oligosaccharide processing, ubiquitination, and proteasome-dependent removal from ER membranes. J. Exp. Med. 187, 835–846.PubMedCrossRefGoogle Scholar
  6. 6.
    Satioh, H., Pu, R. T., and Dasso, M. (1997) SUMO-1: wrestling with a new ubiquitin-related modifier. TIBS 22, 374–376.Google Scholar
  7. 7.
    Narasimhan, J., Potter, J. L., and Haas, A. L. (1996) Conjugation of the 15-kDa interferon-induced ubiquitin homolog is distinct from that of ubiquitin. J. Biol. Chem. 271, 324–330.PubMedCrossRefGoogle Scholar
  8. 8.
    Rock, K. L., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L., Hwang, D., and Goldberg, A. L. (1994) Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78, 761–771.PubMedCrossRefGoogle Scholar
  9. 9.
    Chen, Z., Hagler, J., Palombella, V. J., Melandri, F., Scherer, D., Ballard D., and Maniatis, T. (1995) Signal-induced site-specific phosphorylation targets IkBa to the ubiquitin-proteasome pathway. Genes Devel. 9, 1586–1597.PubMedCrossRefGoogle Scholar
  10. 10.
    Fenteany, G., Standaert, R. F., Reichard, G. A., Corey, E. J., and Schreiber, S. L. (1994) A β-lactone related to lactacystin induces neurite outgrowth in a neuroblastoma cell line and inhibits cell cycle progression in an osteosarcoma cell line. Proc. Natl. Acad. Sci. USA 91, 3358–3362.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc., Totowa, NJ 2000

Authors and Affiliations

  • Allan M. Weissman
    • 1
  1. 1.Laboratory of Immune Cell Biology, Division of Basic Sciences, National Cancer InstituteNIHBethesda

Personalised recommendations